Thomas A. Fitzgerald
CIK: 0001854168
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RNAZ
Transcode Therapeutics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Fitzgerald Thomas A
Fitzgerald Thomas A (SEC CIK 0001854168) files insider reports with the SEC as Chief Financial Officer of Transcode Therapeutics, Inc. (RNAZ).
Signal8 holds 1 ownership filing by Fitzgerald Thomas A, a Form 4, filed on Sep 11, 2026. Those filings report 1 transaction, the latest on Sep 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Fitzgerald Thomas A's filings is in BOSTON, MA.
Recent filings by Fitzgerald Thomas A
- Sep 9, 2026: Grant or award of RNAZ derivative securities (Form 4, code A).
Other insiders filing for Transcode Therapeutics, Inc. (RNAZ)
- Tattory John A, Interim CFO
- DEFJ, LLC, 10% Owner
- CZEREPAK ELIZABETH, Director
- STOVER JACK E, Director